Description
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Purity | ≥98% |
|---|---|
| Formula | C18H18O4 |
| Formula Wt. | 298.33 |
| IUPAC Name | 2-phenylethyl 3-(3-hydroxy-4-methoxyphenyl)propanoate |
| Appearance | White Crystal Powder |
| Store Temp | 4°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Pereira MA. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs. Adv Exp Med Biol. 1999;470:55-63. PMID: 10709674.
Thiopurine antimetabolite; PRPP amidotransferas...
Synthetic somatostatin analog, peptide; somatos...
PDGFR inhibitor.
Indoline; D2/3 agonist.
Light-emitting luciferin analog found in aquati...
Pyrimidine analog; inhibits thymidylate synthas...
Tamoxifen analog; SERM.
BACE1 inhibitor
Bactericidal
Nitrofuran derivative.
PI3K and HDAC inhibitor.
PORCN inhibitor.
Nitrofuran, livestock antibiotic.
ACE inhibitor.
Macrolide; peptidyl transferase inhibitor, prot...
Sulfonamide; dihydropteroate synthase inhibitor...
Peptide; FRP1 antagonist.
SIRT1/2 inhibitor, indirect p53 activator.
5-FU prodrug; thymidylate synthase inhibitor.
VEGFR2, c-Met, RET inhibitor.